Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Evidence update

Surveillance report

2022 exceptional surveillance of chronic obstructive pulmonary disease in over 16s: diagnosis and management

Appendix A: Stakeholder consultation comments table (PDF 669 KB)

2019 exceptional surveillance of chronic obstructive pulmonary disease in over 16s: diagnosis and management (NICE guideline NG115)

Surveillance review decision – July 2014 (PDF 1 MB)

Appendix A: decision matrix – April 2016 (PDF 1.36 MB)

Surveillance report 2016 – Chronic obstructive pulmonary disease in over 16s: diagnosis and management (2010) NICE guideline CG101

Evidence review

Evidence reviews – July 2019 and December 2018

A: Managing pulmonary hypertension and cor pulmonale (PDF 1.83 MB)

B: Oxygen therapy in people with stable COPD (PDF 2.79 MB)

C: Self-management interventions, education and telehealth monitoring (PDF 5.17 MB)

D: Diagnosing COPD and predicting outcomes (PDF 4.35 MB)

E: Predicting and preventing exacerbations (PDF 6.6 MB)

G: Referral criteria for lung volume reduction procedures, bullectomy or lung transplantation (PDF 2.9 MB)

H: Economic model report (PDF 4.5 MB)

I: Inhaled triple therapy (PDF 2.41 MB)

J: Length of corticosteroid use during exacerbations (PDF 1.4 MB)

K: Economic model report for inhaled triple therapy (PDF 1.05 MB)

F: Inhaled therapies (PDF 71.49 MB)

Full guidance

Full guideline (PDF 5.09 MB)